← Back to Search

Five Psycho-educational Session(s) for Lung Cancer

N/A

Recruiting

Led By Lara Traeger, PhD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Completed cancer treatment within past 3 weeks

Documented curative treatment plan including systemic therapy +/- radiation and +/- surgery

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial looks at whether a short educational intervention can improve quality of life for lung cancer patients who are done with active treatment and are just being monitored.

Eligible Conditions

Lung Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You finished cancer treatment within the last three weeks.

Select...

You have a treatment plan that includes medication, radiation, and/or surgery to cure your condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Quality of life: Functional Assessment of Cancer Therapy-Lung Cancer

Secondary outcome measures

Fear of cancer recurrence: Fear of Cancer Recurrence Scale 7

Psychological symptom burden: Hospital Anxiety and Depression Scale

Social isolaton: Campaign to End Loneliness Measurement Tool

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Intervention: Five Psycho-educational SessionsExperimental Treatment1 Intervention

Approximately 6 weeks after the patient's cancer treatment is complete, participants in the intervention arm will proceed to receive up to 5 study sessions (approximately weekly, ~50 minutes each) with a trained interventionist focused on psychoeducational topics. This arm was designed to enhance patient skills to address key concerns during the transition from treatment to surveillance, using a cognitive-behavioral approach. Sessions will be based on an intervention manual.

Group II: Enhanced Usual Care: One Psycho-educational SessionExperimental Treatment1 Intervention

At approximately 6 weeks after treatment completion (as defined by our eligibility criteria), control patients will attend one study session (~50 minutes) with a study clinician. This session is designed to control for patient access and connection to psychosocial resources as recommended in recent work.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,255 Total Patients Enrolled

American Lung AssociationOTHER

31 Previous Clinical Trials

10,873 Total Patients Enrolled

Lara Traeger, PhDPrincipal InvestigatorMassachusetts General Hospital

3 Previous Clinical Trials

323 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant opportunities for participants in this experiment?

"Affirmative. Clinicaltrials.gov has the latest information on this ongoing trial, which first appeared online on September 30th 2021 and was last updated November 9th 2022. A total of 100 candidates are sought from two separate clinical sites for participation in the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Transitions Project: Efficacy Trial

Lara Traeger 2021. "The Transitions Project: Efficacy Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05087251.